8/13/07

Masimo Corp, the inventor of Pulse CO-Oximetry and Read-Through Motion and Low Perfusion pulse oximetry, has announced that its initial public offering of 11,916,626 shares of common stock will be priced at $17 per share.

Selling stockholders are selling 10,416,626 of the shares, with the remainder by Masimo, which has granted the underwriters an option to purchase up to an additional 1,787,494 shares of common stock to cover over-allotments, if any. The company will not receive any proceeds from the sale of shares by the selling stockholders.

The company develops monitoring technologies that can significantly improve patient care, such as the Read-Through Motion and Low Perfusion pulse oximetry, known as SET.